Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis

Xiao Xiao, Zhiguo Liu, Rui Wang, Jiayin Wang, Song Zhang, Xiqiang Cai, Kaichun Wu, Raymond C. Bergan, Li Xu, Daiming Fan

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

Dietary consumption of genistein, found in soy, has been associated with a potentially protective role in colorectal cancer (CRC) development and progression. Herein we demonstrate that genistein will inhibit human CRC cell invasion and migration, that it does so at non-cytotoxic concentrations and we demonstrate this in multiple human CRC cell lines. After orthotopic implantation of human CRC tumors into mice, oral genistein did not inhibit tumor growth, but did inhibit distant metastasis formation, and was non-toxic to mice. Using a qPCR array, we screened for genistein-induced changes in gene expression, followed by Western blot confirmation, demonstrating that genistein downregulated matrix metalloproteinase 2 and Fms- Related Tyrosine Kinase 4 (FLT4; vascular endothelial growth factor receptor 3). After demonstrating that genistein suppressed neo-angiogenesis in mouse tumors, we examined FLT4 expression in primary CRC and adjacent normal colonic tissue from 60 human subjects, demonstrating that increased FLT4 significantly correlates with increased stage and decreased survival. In summary, we demonstrate for the first time that genistein inhibits human CRC metastasis at dietary, non-toxic, doses. FLT4 is identified as a marker of metastatic disease, and as a response marker for small molecule therapeutics that inhibit CRC metastasis.

Original languageEnglish (US)
Pages (from-to)3225-3239
Number of pages15
JournalOncotarget
Volume6
Issue number5
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • Colorectal cancer
  • FLT4
  • Genistein
  • Metastasis
  • Orthotopic mouse model

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis'. Together they form a unique fingerprint.

Cite this